MYC and neoplasm: Many colorectal cancers (CRC) develop loss-of-function mutations in the tumour suppressor APC (adenomatous polyposis coli), resulting in up-regulated MYC mRNA levels and proto-oncogenic activity [40], which has been shown to contribute to tumour initiation [41].